Nifty

:

25549.00

Sensex

:

83755.87

304.25 (1.21%)
1000.36 (1.21%)

Login

Nifty
Sensex

:
:

25549.00
83755.87

304.25 (1.21%)
1000.36 (1.21%)

Sequent Scientific Ltd.

Pharmaceuticals & Drugs - Veterinary

Rating :

60/99

BSE: 512529 | NSE: SEQUENT

Watchlist

NSE BSE

193.99

25-Jun-2025

Open
High
Low
Previous Close

183.84
196.19
183.84
183.21

Volume
Traded Value (lacs)
52 Week High
52 Week Low

1254551
241311731.13
240.7
116.4

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

4,860.92
222.16
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

5,238.23
N/A
6.90

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.40
3.04
-1.03

EBITDA CAGR (%)

10 Years
5 Years
3 Years

11.60
-18.46
-10.91

PAT CAGR (%)

10 Years
5 Years
3 Years

12.82
-50.72
-65.27

P:E (Median)

8 Years
5 Years
3 Years

40.56
60.17
-

P:BV (Average)

8 Years
5 Years
3 Years

4.26
5.26
4.68

EV:EBITDA (Average)

8 Years
5 Years
3 Years

43.96
59.62
82.22

Earnings Forecasts:

(Updated: 06-06-2025)

Description 2024 2025 2026 2027
Adj EPS -1.44 0.88 2.78 5.03
P/E Ratio -134.72 220.44 69.78 38.57
Revenue 1366 1551 1718 1932
EBITDA 61 162 207 303
Net Income -36 22 69 125
ROA -2.3 1.4 6.9 9
P/B Ratio 4.45 6.89 6.54 5.72
ROE -5.29 3.22 11.16 15.86
FCFF -45 -5 79 125
FCFF Yield -0.88 -0.09 1.53 2.44
Net Debt 415 412
BVPS 43.59 28.14 29.66 33.91

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 42.33 36.77 15.12% 36.27 42.21 -14.07% 41.99 49.12 -14.52% 57.67 40.42 42.68%
Expenses 45.15 42.51 6.21% 40.75 46.36 -12.10% 44.09 56.83 -22.42% 59.65 49.49 20.53%
EBITDA -2.82 -5.74 - -4.48 -4.15 - -2.10 -7.71 - -1.98 -9.07 -
EBIDTM -6.66% -15.61% -12.35% -9.83% -5.00% -15.70% -3.43% -22.44%
Other Income 12.27 12.98 -5.47% 11.88 13.44 -11.61% 15.95 9.87 61.60% 10.84 9.70 11.75%
Interest 0.99 1.03 -3.88% 1.17 1.15 1.74% 1.00 1.21 -17.36% 0.81 0.98 -17.35%
Depreciation 2.30 2.11 9.00% 2.24 2.05 9.27% 2.12 2.35 -9.79% 2.00 2.43 -17.70%
PBT 5.91 4.10 44.15% 3.68 6.09 -39.57% 6.41 -1.40 - 6.05 -9.03 -
Tax 1.68 0.34 394.12% 0.87 1.51 -42.38% 2.15 -0.48 - 1.55 -2.23 -
PAT 4.23 3.76 12.50% 2.81 4.58 -38.65% 4.26 -0.92 - 4.50 -6.80 -
PATM 9.99% 10.23% 7.75% 10.85% 10.15% -1.87% 7.80% -16.82%
EPS 0.17 0.15 13.33% 0.11 0.18 -38.89% 0.17 -0.04 - 0.18 -0.27 -

Description Mar 25 Mar 24 Var% Dec 24 Dec 23 Var% Sep 24 Sep 23 Var% Jun 24 Jun 23 Var%
Net Sales 401.70 361.20 11.21% 390.81 329.36 18.66% 368.65 345.97 6.56% 390.21 333.21 17.11%
Expenses 355.46 328.93 8.07% 356.31 307.11 16.02% 329.55 330.84 -0.39% 348.26 341.45 1.99%
EBITDA 46.24 32.27 43.29% 34.50 22.25 55.06% 39.10 15.13 158.43% 41.95 -8.24 -
EBIDTM 11.51% 8.93% 8.83% 6.76% 10.61% 4.37% 10.75% -2.47%
Other Income 1.66 4.00 -58.50% 5.84 4.52 29.20% 4.51 1.65 173.33% 2.68 0.79 239.24%
Interest 15.13 12.44 21.62% 14.95 12.58 18.84% 14.29 12.58 13.59% 16.38 10.48 56.30%
Depreciation 16.12 16.48 -2.18% 16.98 15.46 9.83% 17.10 15.36 11.33% 16.25 14.24 14.12%
PBT 16.31 2.64 517.80% 8.10 1.49 443.62% 7.90 -3.09 - 12.00 -55.68 -
Tax 5.93 1.37 332.85% 1.62 -9.19 - 1.56 3.79 -58.84% 2.94 -21.00 -
PAT 10.38 1.27 717.32% 6.48 10.68 -39.33% 6.34 -6.88 - 9.06 -34.68 -
PATM 2.58% 0.35% 1.66% 3.24% 1.72% -1.99% 2.32% -10.41%
EPS 0.37 -0.04 - 0.14 0.33 -57.58% 0.10 -0.34 - 0.26 -1.40 -

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 178.26 168.52 222.69 219.63 265.46 227.33 166.26 271.20 105.87 394.59 444.82 Net Sales Growth 5.78% -24.33% 1.39% -17.26% 16.77% 36.73% -38.69% 156.16% -73.17% -11.29% Cost Of Goods Sold 105.50 107.89 135.92 108.66 108.87 113.04 94.62 161.37 72.47 218.33 229.86 Gross Profit 72.76 60.63 86.77 110.97 156.59 114.29 71.64 109.83 33.40 176.26 214.95 GP Margin 40.82% 35.98% 38.96% 50.53% 58.99% 50.27% 43.09% 40.50% 31.55% 44.67% 48.32% Total Expenditure 189.64 195.18 249.09 231.59 241.50 205.10 163.57 258.06 121.27 359.06 384.54 Power & Fuel Cost - 12.89 13.93 11.96 12.77 12.73 8.52 2.32 2.14 17.98 20.68 % Of Sales - 7.65% 6.26% 5.45% 4.81% 5.60% 5.12% 0.86% 2.02% 4.56% 4.65% Employee Cost - 30.05 36.66 27.38 22.42 17.10 10.71 25.12 17.90 38.84 45.47 % Of Sales - 17.83% 16.46% 12.47% 8.45% 7.52% 6.44% 9.26% 16.91% 9.84% 10.22% Manufacturing Exp. - 22.39 39.30 48.21 58.70 51.52 41.13 15.87 14.85 56.50 48.54 % Of Sales - 13.29% 17.65% 21.95% 22.11% 22.66% 24.74% 5.85% 14.03% 14.32% 10.91% General & Admin Exp. - 12.12 14.79 16.29 15.28 6.90 7.15 13.02 9.92 15.19 23.99 % Of Sales - 7.19% 6.64% 7.42% 5.76% 3.04% 4.30% 4.80% 9.37% 3.85% 5.39% Selling & Distn. Exp. - 1.55 1.85 2.16 4.02 2.11 1.04 0.83 0.47 4.03 5.71 % Of Sales - 0.92% 0.83% 0.98% 1.51% 0.93% 0.63% 0.31% 0.44% 1.02% 1.28% Miscellaneous Exp. - 8.29 6.65 16.94 19.45 1.68 0.40 39.53 3.53 8.19 5.71 % Of Sales - 4.92% 2.99% 7.71% 7.33% 0.74% 0.24% 14.58% 3.33% 2.08% 2.31% EBITDA -11.38 -26.66 -26.40 -11.96 23.96 22.23 2.69 13.14 -15.40 35.53 60.28 EBITDA Margin -6.38% -15.82% -11.86% -5.45% 9.03% 9.78% 1.62% 4.85% -14.55% 9.00% 13.55% Other Income 50.94 45.98 28.29 38.86 31.30 14.56 13.96 24.67 19.07 15.55 3.56 Interest 3.97 4.36 2.51 1.61 2.68 5.04 3.22 4.54 0.42 16.44 47.46 Depreciation 8.66 8.94 9.12 9.59 9.13 8.95 7.22 14.37 3.25 24.18 26.38 PBT 22.05 6.01 -9.75 15.69 43.45 22.81 6.20 18.90 -0.01 10.46 -9.99 Tax 6.25 -0.86 -3.67 0.89 8.77 1.47 -1.38 2.87 0.00 0.07 1.70 Tax Rate 28.34% 358.33% 37.64% 5.67% 21.45% 6.44% -22.26% 0.70% 0.00% 0.67% 3.95% PAT 15.80 0.62 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 PAT before Minority Interest 15.80 0.62 -6.08 14.80 32.11 21.34 7.59 406.41 -0.01 10.39 41.31 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 8.86% 0.37% -2.73% 6.74% 12.10% 9.39% 4.57% 149.86% -0.01% 2.63% 9.29% PAT Growth 2,448.39% - - -53.91% 50.47% 181.16% -98.13% - - -74.85% EPS 0.63 0.02 -0.24 0.59 1.28 0.85 0.30 16.24 0.00 0.42 1.65

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 1,551.37 1,369.73 1,420.91 1,412.82 1,361.62 1,179.24 1,039.31 1,030.59 683.57 624.98 465.36 Net Sales Growth 13.26% -3.60% 0.57% 3.76% 15.47% 13.46% 0.85% 50.77% 9.37% 34.30% Cost Of Goods Sold 811.85 759.74 833.77 793.00 694.65 605.05 543.01 554.23 356.70 311.71 240.72 Gross Profit 739.52 609.98 587.14 619.82 666.96 574.19 496.30 476.36 326.87 313.27 224.65 GP Margin 47.67% 44.53% 41.32% 43.87% 48.98% 48.69% 47.75% 46.22% 47.82% 50.12% 48.27% Total Expenditure 1,389.58 1,308.32 1,408.95 1,303.43 1,151.68 1,008.92 914.37 919.10 643.03 568.27 444.87 Power & Fuel Cost - 35.46 42.45 33.86 28.75 24.73 23.06 14.66 12.77 26.51 23.32 % Of Sales - 2.59% 2.99% 2.40% 2.11% 2.10% 2.22% 1.42% 1.87% 4.24% 5.01% Employee Cost - 250.57 258.38 231.37 187.22 165.06 145.95 132.07 106.22 88.62 62.39 % Of Sales - 18.29% 18.18% 16.38% 13.75% 14.00% 14.04% 12.81% 15.54% 14.18% 13.41% Manufacturing Exp. - 73.58 86.95 93.67 96.18 83.24 77.73 59.07 57.63 72.14 54.31 % Of Sales - 5.37% 6.12% 6.63% 7.06% 7.06% 7.48% 5.73% 8.43% 11.54% 11.67% General & Admin Exp. - 78.10 75.80 66.90 58.40 56.37 58.35 70.92 48.60 36.44 33.79 % Of Sales - 5.70% 5.33% 4.74% 4.29% 4.78% 5.61% 6.88% 7.11% 5.83% 7.26% Selling & Distn. Exp. - 56.70 58.00 57.11 50.00 45.16 36.29 36.87 28.78 17.46 20.27 % Of Sales - 4.14% 4.08% 4.04% 3.67% 3.83% 3.49% 3.58% 4.21% 2.79% 4.36% Miscellaneous Exp. - 54.16 53.60 27.52 36.47 29.32 29.98 51.29 32.34 15.40 20.27 % Of Sales - 3.95% 3.77% 1.95% 2.68% 2.49% 2.88% 4.98% 4.73% 2.46% 2.16% EBITDA 161.79 61.41 11.96 109.39 209.94 170.32 124.94 111.49 40.54 56.71 20.49 EBITDA Margin 10.43% 4.48% 0.84% 7.74% 15.42% 14.44% 12.02% 10.82% 5.93% 9.07% 4.40% Other Income 14.69 10.96 6.39 10.86 10.49 10.09 8.67 17.20 11.08 14.30 9.96 Interest 60.75 48.09 35.52 15.77 24.38 35.71 32.80 39.70 28.34 38.56 44.37 Depreciation 66.45 61.54 55.69 51.54 50.60 50.62 41.92 53.30 40.07 46.22 32.94 PBT 44.31 -37.26 -72.86 52.93 145.45 94.08 58.88 35.70 -16.80 -13.77 -46.85 Tax 12.05 -25.03 -15.68 8.17 32.18 12.03 2.01 13.46 -0.41 2.62 3.39 Tax Rate 27.19% 45.80% 11.39% 15.44% 23.55% 12.79% 3.41% 3.03% 2.44% -19.03% -40.50% PAT 32.26 -35.87 -121.16 40.95 95.44 69.91 48.66 421.57 -13.83 -18.47 -10.74 PAT before Minority Interest 21.88 -29.61 -121.98 44.76 104.45 82.05 56.88 430.83 -16.39 -16.39 -11.76 Minority Interest -10.38 -6.26 0.82 -3.81 -9.01 -12.14 -8.22 -9.26 2.56 -2.08 1.02 PAT Margin 2.08% -2.62% -8.53% 2.90% 7.01% 5.93% 4.68% 40.91% -2.02% -2.96% -2.31% PAT Growth 208.95% - - -57.09% 36.52% 43.67% -88.46% - - - EPS 1.29 -1.43 -4.84 1.64 3.81 2.79 1.94 16.84 -0.55 -0.74 -0.43

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 1,087.23 1,058.36 1,041.09 1,029.51 886.22 917.79 948.62 1,257.33 1,205.88 156.92 Share Capital 49.89 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 Total Reserves 960.03 952.25 944.32 972.07 822.45 849.53 882.29 1,193.03 1,134.19 92.50 Non-Current Liabilities -9.38 -9.43 19.26 4.80 11.50 36.20 19.01 38.28 42.08 79.95 Secured Loans 0.00 0.00 0.00 0.00 15.16 20.61 0.00 13.98 23.82 56.70 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.35 Long Term Provisions 2.21 2.54 24.51 6.59 4.09 22.30 24.39 28.88 22.84 22.97 Current Liabilities 98.16 61.61 89.56 96.62 105.24 79.87 26.69 168.71 109.89 427.45 Trade Payables 38.45 36.71 57.56 58.75 64.34 52.60 24.56 69.96 73.64 69.81 Other Current Liabilities 12.64 4.67 5.20 2.85 9.30 6.01 1.91 35.29 20.85 86.85 Short Term Borrowings 46.45 19.10 15.50 5.22 14.39 19.27 0.00 63.22 15.04 270.29 Short Term Provisions 0.61 1.13 11.30 29.81 17.22 1.99 0.21 0.24 0.36 0.51 Total Liabilities 1,176.01 1,110.54 1,149.91 1,130.93 1,002.96 1,033.86 994.32 1,464.32 1,357.85 664.32 Net Block 42.52 56.72 66.90 65.78 69.41 52.42 23.68 181.67 169.60 200.88 Gross Block 87.15 110.96 113.09 102.86 99.30 73.33 37.61 230.34 193.00 302.01 Accumulated Depreciation 44.63 54.24 46.19 37.08 29.89 20.90 13.93 48.67 23.40 101.13 Non Current Assets 1,070.83 1,025.43 995.04 985.95 879.01 946.46 853.77 1,095.85 1,056.39 421.95 Capital Work in Progress 5.14 2.20 1.40 4.34 3.72 0.03 3.12 32.26 19.97 8.93 Non Current Investment 640.30 632.47 658.47 685.11 738.95 788.16 672.67 834.62 834.87 183.11 Long Term Loans & Adv. 382.30 333.48 267.65 230.43 65.53 83.27 138.79 26.79 23.08 26.30 Other Non Current Assets 0.56 0.56 0.61 0.29 1.39 22.57 15.51 20.52 8.86 2.73 Current Assets 96.78 75.02 154.86 144.99 123.95 87.41 140.54 368.46 301.47 242.38 Current Investments 0.11 0.05 0.14 0.07 18.75 0.10 13.98 62.28 62.29 0.08 Inventories 34.54 47.95 67.99 45.79 31.42 25.33 13.83 62.53 56.19 66.88 Sundry Debtors 44.79 13.65 52.42 61.44 40.79 42.90 78.47 113.03 73.75 98.77 Cash & Bank 0.96 0.18 12.89 0.74 3.72 1.88 3.04 3.06 4.80 27.38 Other Current Assets 16.38 1.00 1.74 3.56 29.27 17.21 31.22 127.56 104.45 49.28 Short Term Loans & Adv. 13.54 12.21 19.69 33.40 25.66 15.65 30.09 114.68 86.38 30.28 Net Current Assets -1.38 13.42 65.31 48.37 18.71 7.54 113.85 199.75 191.58 -185.08 Total Assets 1,167.61 1,100.45 1,149.90 1,130.94 1,002.96 1,033.87 994.31 1,464.31 1,357.86 664.33

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 656.56 698.78 692.10 727.65 687.10 706.69 647.58 976.79 945.71 91.27 Share Capital 49.89 49.89 49.67 49.67 49.67 49.37 48.75 48.75 47.65 30.48 Total Reserves 529.37 592.57 595.33 670.21 623.34 638.43 581.25 912.49 874.01 26.85 Non-Current Liabilities 122.08 175.81 209.11 153.58 216.46 214.75 227.13 246.20 299.72 277.55 Secured Loans 123.76 113.95 87.25 62.52 108.88 126.94 85.14 141.76 197.50 249.97 Unsecured Loans 18.96 36.16 35.21 31.18 41.18 20.90 18.40 23.38 13.82 0.35 Long Term Provisions 21.75 21.47 55.95 27.19 13.16 30.50 28.54 34.76 28.66 25.70 Current Liabilities 626.99 558.76 537.35 513.11 514.86 440.41 430.93 663.55 290.37 406.09 Trade Payables 260.26 244.34 258.05 226.91 220.38 209.35 160.49 203.04 143.94 90.94 Other Current Liabilities 109.56 109.57 78.99 100.64 104.98 87.80 106.52 259.26 83.23 107.43 Short Term Borrowings 245.87 182.09 159.54 102.91 147.12 127.36 152.41 194.70 56.04 204.31 Short Term Provisions 11.31 22.76 40.77 82.66 42.38 15.90 11.51 6.54 7.17 3.42 Total Liabilities 1,462.03 1,483.76 1,486.57 1,443.00 1,463.16 1,402.10 1,342.62 1,903.76 1,538.02 921.84 Net Block 591.95 605.31 564.44 535.66 576.57 498.14 475.97 684.33 586.48 474.43 Gross Block 959.12 939.83 825.09 753.25 762.46 638.06 581.74 789.60 643.70 596.25 Accumulated Depreciation 367.17 334.52 260.64 217.60 185.89 139.91 105.77 105.27 57.22 121.82 Non Current Assets 639.17 693.88 678.16 676.33 738.86 795.99 804.61 1,176.02 1,047.48 612.00 Capital Work in Progress 15.93 55.28 11.63 30.79 13.42 22.61 18.04 32.55 23.52 39.06 Non Current Investment 0.89 0.01 36.79 76.94 131.29 179.65 221.73 363.97 360.58 58.04 Long Term Loans & Adv. 18.99 21.74 53.92 32.15 14.40 32.27 31.01 37.51 30.35 36.01 Other Non Current Assets 11.41 11.54 11.37 0.79 3.18 63.31 57.86 57.66 46.54 4.47 Current Assets 810.94 779.79 808.41 766.68 724.30 606.12 538.01 727.74 490.54 309.84 Current Investments 2.61 0.05 1.44 5.66 40.18 0.47 17.34 64.12 66.98 0.58 Inventories 346.23 346.09 347.97 264.36 219.42 200.10 158.57 160.81 135.08 94.36 Sundry Debtors 335.63 340.96 329.24 346.14 318.76 278.25 258.35 254.62 192.39 115.44 Cash & Bank 69.83 41.75 59.25 56.20 75.83 72.04 42.45 47.40 25.30 38.46 Other Current Assets 56.63 7.74 7.68 16.82 70.12 55.26 61.30 200.79 70.80 61.01 Short Term Loans & Adv. 46.26 43.21 62.83 77.52 55.33 46.75 56.05 54.48 46.69 41.86 Net Current Assets 183.95 221.03 271.06 253.57 209.44 165.71 107.08 64.19 200.17 -96.25 Total Assets 1,450.11 1,473.67 1,486.57 1,443.01 1,463.16 1,402.11 1,342.62 1,903.76 1,538.02 921.84

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity -26.94 37.75 9.36 2.34 30.20 73.80 -4.02 -24.04 100.02 -24.99 PBT -0.24 -9.75 15.69 43.45 22.81 6.20 409.27 -0.01 10.46 43.01 Adjustment -18.19 -0.49 -6.38 1.12 1.74 -2.19 -392.74 20.30 33.58 22.54 Changes in Working Capital -10.77 48.68 1.81 -25.47 7.84 70.32 -21.10 -42.97 56.92 -89.22 Cash after chg. in Working capital -29.20 38.45 11.12 19.09 32.39 74.34 -4.57 -22.68 100.95 -23.68 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 2.25 -0.70 -1.75 -16.76 -2.19 -0.54 0.55 -1.36 -0.93 -1.31 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 5.47 -50.70 -4.25 16.55 -17.68 -114.06 15.60 -46.84 -359.41 23.65 Net Fixed Assets 20.87 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 Net Investments -7.89 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 Others -7.51 -78.12 -23.53 -51.79 -18.58 20.18 -416.52 2.53 256.59 103.21 Cash from Financing Activity 22.32 0.24 7.25 -21.33 -10.71 40.34 -11.78 70.97 247.38 7.96 Net Cash Inflow / Outflow 0.84 -12.71 12.36 -2.44 1.81 0.07 -0.19 0.09 -12.01 6.62 Opening Cash & Equivalents 0.08 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.11 6.48 Closing Cash & Equivalent 0.93 0.08 12.80 0.44 2.87 1.07 1.00 1.19 1.10 13.10

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 30.59 16.81 30.59 114.75 115.33 116.02 45.24 -7.19 -0.05 -23.55 PBT -54.65 -137.66 52.93 145.45 94.08 58.88 445.79 -16.80 -13.77 -8.37 Adjustment 144.97 220.72 93.73 83.98 91.41 84.47 -313.85 123.31 83.81 35.92 Changes in Working Capital -45.67 -51.61 -89.30 -70.89 -58.30 -27.95 -77.87 -104.37 -71.46 -53.98 Cash after chg. in Working capital 44.65 31.45 57.36 158.55 127.18 115.40 54.06 2.14 -1.42 -26.44 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -14.06 -14.64 -26.77 -43.79 -11.85 0.62 -8.83 -9.33 1.37 2.89 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity -5.92 -64.96 -95.57 9.65 -72.27 -67.69 7.17 -116.18 -315.83 -154.69 Net Fixed Assets 20.87 1.33 -7.29 -4.18 -29.66 -32.63 221.87 -49.63 97.97 38.51 Net Investments -7.89 26.09 26.57 72.52 30.56 -101.61 210.25 0.26 -713.97 -118.07 Others -18.90 -92.38 -114.85 -58.69 -73.17 66.55 -424.95 -66.81 300.17 -75.13 Cash from Financing Activity -1.44 32.23 67.26 -138.75 -42.75 -20.08 -56.96 147.44 308.69 179.41 Net Cash Inflow / Outflow 23.24 -15.92 2.29 -14.35 0.31 28.25 -4.55 24.07 -7.19 1.17 Opening Cash & Equivalents 41.57 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.85 22.96 Closing Cash & Equivalent 64.81 41.57 57.50 53.74 68.10 67.79 39.54 44.10 20.03 21.83

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 40.49 40.18 40.02 41.14 35.11 36.41 38.20 50.95 49.61 8.07 ROA 0.05% -0.54% 1.30% 3.01% 2.10% 0.75% 33.06% 0.00% 1.03% 6.67% ROE 0.06% -0.61% 1.47% 3.39% 2.41% 0.83% 37.41% 0.00% 1.59% 51.35% ROCE 0.37% -0.68% 1.65% 4.45% 2.96% 0.99% 36.09% 0.03% 3.07% 20.15% Fixed Asset Turnover 1.74 2.01 2.04 2.66 2.66 3.00 2.05 0.52 1.65 1.45 Receivable days 61.84 53.54 94.31 69.43 66.55 132.93 127.17 310.76 77.04 70.28 Inventory Days 87.31 93.97 94.25 52.44 45.13 42.89 50.71 197.54 54.96 66.23 Payable days 127.14 126.58 195.35 206.34 103.60 86.82 78.05 239.99 74.47 102.24 Cash Conversion Cycle 22.01 20.93 -6.79 -84.46 8.08 88.99 99.83 268.31 57.53 34.27 Total Debt/Equity 0.05 0.02 0.02 0.01 0.04 0.05 0.00 0.07 0.04 2.77 Interest Cover 0.95 -2.88 10.75 16.26 5.53 2.93 91.09 0.97 1.64 1.91

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 23.22 25.76 25.97 28.98 27.10 27.86 25.85 39.44 38.69 3.76 ROA -2.01% -8.21% 3.06% 7.19% 5.73% 4.14% 26.54% -0.95% -1.33% -1.52% ROE -4.85% -18.95% 6.56% 15.00% 12.06% 8.63% 54.15% -1.74% -3.35% -28.10% ROCE -0.60% -9.71% 7.01% 16.24% 12.59% 9.24% 41.28% 0.87% 2.72% 6.93% Fixed Asset Turnover 1.49 1.65 1.83 1.80 1.72 1.74 1.51 0.96 1.03 1.01 Receivable days 87.51 84.11 85.48 89.12 90.45 92.53 90.49 118.40 87.75 74.80 Inventory Days 89.54 87.10 77.50 64.84 63.56 61.85 56.34 78.37 65.41 73.58 Payable days 121.21 109.97 111.61 117.51 80.72 75.36 77.04 104.11 77.28 87.31 Cash Conversion Cycle 55.84 61.25 51.38 36.45 73.29 79.02 69.78 92.66 75.87 61.07 Total Debt/Equity 0.78 0.62 0.49 0.31 0.51 0.47 0.48 0.43 0.34 8.26 Interest Cover -0.14 -2.88 4.36 6.60 3.63 2.80 12.19 0.41 0.64 0.81

Top Investors:

quant mutual fund - quant healthcare fund

ashoka whiteoak icav - ashoka whiteoak india oppor

investor education and protection fund (iepf)

Annual Reports:

News Update:

SeQuent secures approvals from NSE and BSE for proposed merger with Viyash Life Sciences
29th May 2025, 12:59 PM

Under the agreed terms, shareholders of Viyash will receive 56 SeQuent shares for every 100 Viyash shares held
Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback